Ligand‐Induced Stabilization and Activation of Peroxisome Proliferator‐Activated Receptor γ

Osman A. B. S. M. Gani , Ingebrigt Sylte
Chemical Biology & Drug Design 72 ( 1) 50 -57

9
2008
Molecular recognition of long chain fatty acids by peroxisome proliferator-activated receptor α

Osman A. B. S. M. Gani , Ingebrigt Sylte
Medicinal Chemistry Research 18 ( 1) 8 -19

3
2009
Protein kinase inhibition of clinically important staurosporine analogues

Osman A. B. S. M. Gani , Richard A. Engh
Natural Product Reports 27 ( 4) 489 -498

87
2010
Data driven polypharmacological drug design for lung cancer: analyses for targeting ALK, MET, and EGFR

Dilip Narayanan , Osman A. B. S. M. Gani , Franz X. E. Gruber , Richard A. Engh
Journal of Cheminformatics 9 ( 1) 43 -43

4
2017
Evaluating the Predictivity of Virtual Screening for Abl Kinase Inhibitors to Hinder Drug Resistance

Osman A. B. S. M. Gani , Dilip Narayanan , Richard A. Engh
Chemical Biology & Drug Design 82 ( 5) 506 -519

6
2013
Theoretical Calculations of the Catalytic Triad in Short-Chain Alcohol Dehydrogenases/Reductases

Osman A.B.S.M. Gani , Olayiwola A. Adekoya , Laura Giurato , Francesca Spyrakis
Biophysical Journal 94 ( 4) 1412 -1427

21
2008
Structural origins of AGC protein kinase inhibitor selectivities: PKA as a drug discovery tool.

Espen Åberg , Bjarte Lund , Alexander Pflug , Osman A.B.S.M. Gani
Biological Chemistry 393 ( 10) 1121 -1129

7
2012
Molecular recognition of Docosahexaenoic acid by peroxisome proliferator-activated receptors and retinoid-X receptor α

Osman A.B.S.M. Gani , Ingebrigt Sylte
Journal of Molecular Graphics and Modelling 27 ( 2) 217 -224

46
2008
1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin

Kristin Odlo , Jean Hentzen , Jérémie Fournier dit Chabert , Sylvie Ducki
Bioorganic & Medicinal Chemistry 16 ( 9) 4829 -4838

136
2008
1,2,3-Triazole analogs of combretastatin A-4 as potential microtubule-binding agents

Kristin Odlo , Jérémie Fournier-Dit-Chabert , Sylvie Ducki , Osman A.B.S.M. Gani
Bioorganic & Medicinal Chemistry 18 ( 18) 6874 -6885

62
2010
Signposts of docking and scoring in drug design.

Osman A .B. S. M. Gani
Chemical Biology & Drug Design 70 ( 4) 360 -365

9
2007
Structural insight into a CE15 esterase from the marine bacterial metagenome.

Concetta De Santi , Osman ABSM Gani , Ronny Helland , Adele Williamson
Scientific Reports 7 ( 1) 17278 -17278

10
2017
a clinical-stage peptide Menu

Osman ABSM Gani , Richard A Engh

Assessing protein kinase target similarity: Comparing sequence, structure, and cheminformatics approaches.

Osman A. Gani , Balmukund Thakkar , Dilip Narayanan , Kazi A. Alam
Biochimica et Biophysica Acta 1854 ( 10) 1605 -1616

9
2015
20
2021
Phenotype-specific differences in polygenicity and effect size distribution across functional annotation categories revealed by AI-MiXeR

Alexey A Shadrin , Oleksandr Frei , Olav B Smeland , Francesco Bettella
Bioinformatics 36 ( 18) 4749 -4756

2
2020
9 SHARED GENETIC ARCHITECTURE BETWEEN AUTISM SPECTRUM DISORDER, LONELINESS AND INTELLIGENCE

Osman Gani , Terje Nærland , Oleksandr Frei , Anne L. Høyland
European Neuropsychopharmacology 29

2019
2019